Vol 5, No 12 (2025)

decorative image of the issue cover

Reimbursement Recommendations

Inavolisib (Itovebi)

CDA-AMC

Published December 15, 2025

PDF HTML ePub

Nivolumab Plus Ipilimumab (Opdivo Plus Yervoy)

CDA-AMC

Published December 12, 2025

PDF HTML ePub

Vorasidenib (Voranigo)

CDA-AMC

Published December 12, 2025

PDF HTML ePub

Tofersen (Qalsody)

CDA-AMC

Published December 10, 2025

PDF HTML ePub

Vanzacaftor-Tezacaftor-Deutivacaftor (Alyftrek)

CDA-AMC

Published December 5, 2025

PDF HTML ePub

Ibrutinib

CDA-AMC

Published December 4, 2025

PDF HTML ePub

Fecal Microbiota (Rebyota)

CDA-AMC

Published December 1, 2025

PDF HTML ePub

Delgocitinib (Anzupgo)

CDA-AMC

Published December 1, 2025

PDF HTML ePub

Reimbursement Reviews

Quizartinib (Vanflyta)

CDA-AMC

Published December 24, 2025

PDF HTML ePub

Cipaglucosidase Alfa (Pombiliti) With Miglustat (Opfolda)

CDA-AMC

Published December 22, 2025

PDF HTML ePub

Abemaciclib (Verzenio)

CDA-AMC

Published December 22, 2025

PDF HTML ePub

Abemaciclib (Verzenio)

CDA-AMC

Published December 19, 2025

PDF HTML ePub

Pembrolizumab (Keytruda)

CDA-AMC

Published December 19, 2025

PDF HTML ePub

Dupilumab (Dupixent)

CDA-AMC

Published December 18, 2025

PDF HTML ePub

Dupilumab (Dupixent)

CDA-AMC

Published December 17, 2025

PDF HTML ePub

Darolutamide (Nubeqa)

CDA-AMC

Published December 17, 2025

PDF HTML ePub

Lazertinib and Amivantamab (Lazcluze and Rybrevant)

CDA-AMC

Published December 16, 2025

PDF HTML ePub

Health Technology Reviews

Federal Policies and Public Reimbursement of Pediatric Medicines in Canada

CDA-AMC

Published December 15, 2025

PDF HTML ePub

View All Issues